LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article: Multichromatic phenotyping of HER receptor coexpression in breast tumor tissue samples using flow cytometry--Possibilities and limitations

    Vollmann-Zwerenz, Arabel / Diermeier-Daucher, Simone / Wege, Anja Kathrin / Sassen, Andrea / Schmidt-Brücken, Elisabeth / Hofstaedter, Ferdinand / Ortmann, Olaf / Nauwelaers, Frans / Brockhoff, Gero

    Cytometry. Part A. 2010 Apr., v. 77A, no. 4

    2010  

    Abstract: The prognostic significance of HER2 expression in human breast carcinomas is beyond dispute nowadays. The HER family of receptor tyrosine kinases comprises four members (HER1/ErbB1/EGFR, HER2/ErbB2, HER3/ErbB3, and HER4/ErbB4) that act in concert via ... ...

    Abstract The prognostic significance of HER2 expression in human breast carcinomas is beyond dispute nowadays. The HER family of receptor tyrosine kinases comprises four members (HER1/ErbB1/EGFR, HER2/ErbB2, HER3/ErbB3, and HER4/ErbB4) that act in concert via transactivation and consequently compose a functional signaling unit. Besides HER2 overexpression, coexpression of other HER receptors has substantial impact on course of disease and potential therapeutic benefit. This observation is substantiated by numerous preclinical studies and retrospective studies done on patients with breast cancer. Against this background, the quantification of all HER receptor expressions at the same time would significantly extend the information content revealed by routine diagnosis of breast cancer tissues. Moreover, the knowledge of HER receptor coexpression profiles in primary tumor samples could provide the basis to design and develop highly specific antireceptor treatment strategies. Here, we report on a simultaneous flow cytometric detection of all four HER receptors on carcinoma cells isolated from primary breast cancer tissues and separated from nonepithelial cells by cytokeratin staining. Combined with DNA, i.e. ploidy quantification, the approach resulted in a six-parameter assay that could complement the diagnosis of a variety of diseases in which HER receptor expression has a pivotal impact on the degree of malignancy. © 2010 International Society for Advancement of Cytometry
    Language English
    Dates of publication 2010-04
    Size p. 387-398.
    Publishing place Wiley Subscription Services, Inc., A Wiley Company
    Document type Article
    ISSN 1552-4922
    DOI 10.1002/cyto.a.20868
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  2. Article ; Online: Multichromatic phenotyping of HER receptor coexpression in breast tumor tissue samples using flow cytometry--possibilities and limitations.

    Vollmann-Zwerenz, Arabel / Diermeier-Daucher, Simone / Wege, Anja Kathrin / Sassen, Andrea / Schmidt-Brücken, Elisabeth / Hofstaedter, Ferdinand / Ortmann, Olaf / Nauwelaers, Frans / Brockhoff, Gero

    Cytometry. Part A : the journal of the International Society for Analytical Cytology

    2010  Volume 77, Issue 4, Page(s) 387–398

    Abstract: The prognostic significance of HER2 expression in human breast carcinomas is beyond dispute nowadays. The HER family of receptor tyrosine kinases comprises four members (HER1/ErbB1/EGFR, HER2/ErbB2, HER3/ErbB3, and HER4/ErbB4) that act in concert via ... ...

    Abstract The prognostic significance of HER2 expression in human breast carcinomas is beyond dispute nowadays. The HER family of receptor tyrosine kinases comprises four members (HER1/ErbB1/EGFR, HER2/ErbB2, HER3/ErbB3, and HER4/ErbB4) that act in concert via transactivation and consequently compose a functional signaling unit. Besides HER2 overexpression, coexpression of other HER receptors has substantial impact on course of disease and potential therapeutic benefit. This observation is substantiated by numerous preclinical studies and retrospective studies done on patients with breast cancer. Against this background, the quantification of all HER receptor expressions at the same time would significantly extend the information content revealed by routine diagnosis of breast cancer tissues. Moreover, the knowledge of HER receptor coexpression profiles in primary tumor samples could provide the basis to design and develop highly specific antireceptor treatment strategies. Here, we report on a simultaneous flow cytometric detection of all four HER receptors on carcinoma cells isolated from primary breast cancer tissues and separated from nonepithelial cells by cytokeratin staining. Combined with DNA, i.e. ploidy quantification, the approach resulted in a six-parameter assay that could complement the diagnosis of a variety of diseases in which HER receptor expression has a pivotal impact on the degree of malignancy.
    MeSH term(s) Animals ; Antibody Specificity/immunology ; Blotting, Western ; Breast Neoplasms/diagnosis ; Breast Neoplasms/enzymology ; Breast Neoplasms/pathology ; Cell Line, Tumor ; DNA, Neoplasm/metabolism ; Female ; Flow Cytometry/methods ; Humans ; Mice ; NIH 3T3 Cells ; Phenotype ; Receptor Protein-Tyrosine Kinases/metabolism ; Staining and Labeling
    Chemical Substances DNA, Neoplasm ; Receptor Protein-Tyrosine Kinases (EC 2.7.10.1)
    Language English
    Publishing date 2010-04
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2099868-5
    ISSN 1552-4930 ; 0196-4763 ; 1552-4922
    ISSN (online) 1552-4930
    ISSN 0196-4763 ; 1552-4922
    DOI 10.1002/cyto.a.20868
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top